Search Within

Donavan Tai Suan Cheng

Formats
  1. Meeting Abstract (36)
  2. Journal Article (16)
Groups
  1. Department of Pathology and Laboratory Medicine (49)
  2. GSK Faculty (49)
  3. Human Oncology and Pathogenesis Program (49)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (44)
  5. Tow Center for Developmental Oncology (TCDO) (35)
  6. Department of Medicine (27)

More Groups

People
  1. Michael Berger (42)
  2. Ahmet Zehir (37)
  3. Marc Ladanyi (34)
  4. Maria Arcila (33)
  5. Khedoudja Nafa (19)
  6. David Solit (13)

More People

Years
  1. 2017 (5)
  2. 2016 (4)
  3. 2015 (23)
  4. 2014 (13)
  5. 2013 (7)
Publications
  1. Journal of Molecular Diagnostics (18)
  2. Journal of Clinical Oncology (7)
  3. Laboratory Investigation (6)
  4. Modern Pathology (6)
  5. American Journal of Respiratory and Critical Care Medicine (1)
  6. BMC Medical Genomics (1)

More Publications

Publishers
  1. Elsevier Science, Inc. (18)
  2. American Society of Clinical Oncology (8)
  3. Nature Publishing Group (7)
  4. Nature Research (6)
  5. Elsevier Inc. (3)
  6. American Association for Cancer Research (2)

More Publishers

Results (52)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next-generation sequencing of matched normal blood identifies clonal hematopoiesis in a significant subset of solid tumor patients without hematologic malignancies
    Meeting Abstract

    Coombs, C. C.; Zehir, A.; Devlin, S.; Middha, S.; Cheng, D.; Kishtagari, A.; Hyman, D. M.; Solit, D.; Robson, M.; Baselga, J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Precision medicine at Memorial Sloan Kettering Cancer Center: Clinical next-generation sequencing enabling next-generation targeted therapy trials
    Journal Article

    Hyman, D. M.; Solit, D. B.; Arcila, M. E.; Cheng, D. T.; Sabbatini, P.; Baselga, J.; Berger, M. F.; Ladanyi, M.
    Drug Discovery Today (2015)

    Fulltext@MSK | Save
  • Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway
    Journal Article

    Murali, R.; Chandramohan, R.; Mòˆller, I.; Scholz, S. L.; Berger, M.; Huberman, K.; Viale, A.; Pirun, M.; Socci, N. D.; Bouvier, N.; more...
    Oncotarget (2015)

    Fulltext@MSK | Save
  • Tumor relevant germline findings in targeted tumor sequencing using matched normal DNA of 1,570 unselected cases
    Meeting Abstract

    Schrader, K. A.; Cheng, D. T.; Vijai, J.; Prasad, M.; Walsh, M.; Zehir, A.; Thomas, T.; Benayed, R.; Stadler, Z. K.; Ashraf, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The clinical utility of ERBB2 amplification detection in breast carcinoma using a 341 gene hybrid capture-based next generation sequencing (NGS) assay: Comparison with standard immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) assays
    Meeting Abstract

    Ross, D. S.; Zehir, A.; Cheng, D. T.; Nafa, K.; Jour, G.; Razavi, P.; Hyman, D. M.; Baselga, J.; Berger, M. F.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Is next generation sequencing (NGS) ready for routine clinical practice in gliomas? Results of a prospective study utilizing the MSK-IMPACT assay
    Meeting Abstract

    Omuro, A. M. P.; Zehir, A.; Cheng, D. T.; Berger, M. F.; Hyman, D. M.; Solit, D. B.; Baselga, J.; Ladanyi, M.; Arcila, M. E.; Hameed, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Identification of novel and potentially targetable receptor tyrosine kinase alterations in colorectal carcinoma using a 341 gene hybrid capture-based next-generation sequencing assay
    Meeting Abstract

    Hechtman, J. F.; Arcila, M. E.; Cheng, D. T.; Solit, D. B.; Yaeger, R. D.; Hyman, D. M.; Berger, M. F.; Shia, J.; Vakiani, E.; Zehir, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Comparison of genetic alterations from the bladder cancer genome atlas (TCGA) and a prospective set of high-grade urothelial carcinoma tumors using a CLIA laboratory next generation sequencing assay
    Meeting Abstract

    Iyer, G.; Bagrodia, A.; Cha, E. K.; Boyd, M. E.; Zehir, A.; Cheng, D. T.; Hyman, D. M.; Bambury, R. M.; Arcila, M. E.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A retrospective evaluation of vemurafenib as treatment for BRAF-mutant melanoma brain metastases
    Journal Article

    Harding, J. J.; Catalanotti, F.; Munhoz, R. R.; Cheng, D. T.; Yaqubie, A.; Kelly, N.; McDermott, G. C.; Kersellius, R.; Merghoub, T.; Lacouture, M. E.; more...
    The Oncologist (2015)

    Fulltext@MSK | Save
  • Translational bioinformatics and clinical research (biomedical) informatics
    Journal Article

    Sirintrapun, S. J.; Zehir, A.; Syed, A.; Gao, J.; Schultz, N.; Cheng, D. T.
    Surgical Pathology Clinics (2015)

    Fulltext@MSK | Save